Lipe & Dalton’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-43,335
| Closed | -$3.33M | – | 97 |
|
|
2020
Q2 | $3.33M | Sell |
43,335
-4,150
| -9% | -$319K | 2.42% | 16 |
|
|
2020
Q1 | $3.55M | Sell |
47,485
-4,650
| -9% | -$348K | 3% | 9 |
|
|
2019
Q4 | $3.39M | Sell |
52,135
-2,487
| -5% | -$162K | 2.25% | 17 |
|
|
2019
Q3 | $3.46M | Sell |
54,622
-2,079
| -4% | -$132K | 2.53% | 14 |
|
|
2019
Q2 | $3.83M | Sell |
56,701
-53
| -0.1% | -$3.58K | 2.74% | 14 |
|
|
2019
Q1 | $3.69M | Sell |
56,754
-774
| -1% | -$50.3K | 2.71% | 14 |
|
|
2018
Q4 | $3.6M | Sell |
57,528
-5,499
| -9% | -$344K | 2.93% | 13 |
|
|
2018
Q3 | $4.87M | Buy |
63,027
+1,501
| +2% | +$116K | 3.32% | 9 |
|
|
2018
Q2 | $4.36M | Buy |
61,526
+10,966
| +22% | +$777K | 3.21% | 9 |
|
|
2018
Q1 | $3.81M | Buy |
50,560
+1,135
| +2% | +$85.6K | 2.73% | 16 |
|
|
2017
Q4 | $3.54M | Sell |
49,425
-1,105
| -2% | -$79.2K | 2.45% | 22 |
|
|
2017
Q3 | $4.09M | Buy |
50,530
+340
| +0.7% | +$27.5K | 2.88% | 13 |
|
|
2017
Q2 | $3.55M | Buy |
50,190
+11,575
| +30% | +$819K | 2.3% | 18 |
|
|
2017
Q1 | $2.62M | Buy |
38,615
+2,360
| +7% | +$160K | 1.9% | 26 |
|
|
2016
Q4 | $2.6M | Sell |
36,255
-2,470
| -6% | -$177K | 1.85% | 26 |
|
|
2016
Q3 | $3.06M | Buy |
38,725
+9,675
| +33% | +$766K | 2.05% | 24 |
|
|
2016
Q2 | $2.42M | Buy |
29,050
+1,440
| +5% | +$120K | 1.67% | 26 |
|
|
2016
Q1 | $2.54M | Buy |
27,610
+5,570
| +25% | +$512K | 1.99% | 23 |
|
|
2015
Q4 | $2.23M | Buy |
+22,040
| New | +$2.23M | 1.81% | 24 |
|